NorthEdge scores first exit with Accrol IPO
Accrol Group, a UK-based tissue manufacturer backed by NorthEdge Capital, has listed on AIM with a ТЃ93m market cap.
Shares were priced at 100 pence apiece, allowing the business to raise £63.5m. Its enterprise value reached £116m. The company stated it would use the proceeds of the placing of new shares to repay all shareholder loan notes and refinance existing debt.
NorthEdge will retain a 15% stake in the company following the listing. The IPO marks the first divestment for the firm, which launched its £225m maiden fund in 2013. The GP secured a 46% stake in the business in 2014 via this maiden fund, in a deal that valued the tissue producer at £66m.
Zeus Capital brokered the IPO.
Company
Founded in 1993 and headquartered in Blackburn, Accrol manufactures soft paper products such as kitchen towels, toilet rolls, napkins and facial tissues. The company supplies both the branded and private label sectors.
According to publicly available information, Accrol generated a £101m turnover in 2014/15, with EBITDA of £10m.
People
NorthEdge Capital – Dan Wright (COO).
Accrol Group – Majid Hussain (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








